Validated Roadmap & Execution Power ~ Build Investor Trust
Founders Frequently Ask
- What milestones do we need to achieve, and how much capital is required to get there?
- How do we execute efficiently, given the interdependencies, risks, and limited runway?
Major Challenges
Milestone Misalignment: Many startups approach regulatory, development, clinical, and fundraising efforts in silos. This fragmentation leads to slower progress, misaligned priorities, and difficulty securing funding. In the best case, it results in premature exits and founder dilution.
Execution Gaps: Without experienced leadership to drive execution, startups risk costly mistakes, missed milestones, and loss of investor confidence.
At Eliomedica, we provide a structured, execution-driven approach to medical device commercialization. Our Roadmapping & Execution service helps founders:
- Define a clear commercialization path with validated milestones.
- Align regulatory, development, and market-entry strategies to optimize execution and mitigate risks.
- Build investor confidence by demonstrating strong execution capabilities.
Our Approach
Milestone Setting: We map out the commercialization journey, defining critical milestones to secure funding or reach key business objectives.
Risk Management: We proactively identify risks — regulatory, supply chain, technical, Go-to-Market — and implement mitigation strategies. As our own David Pyron says: “You manage risks, Issues manage you.”
Cross-Team Integration: We bridge gaps between engineering, regulatory, clinical, and fundraising efforts to maintain alignment and accelerate progress. We also ensure efficient allocation of capital and talent while staying within budget.
External Coordination: We manage critical partnerships and communication with suppliers, manufacturers, and test houses, ensuring seamless execution and compliance.
Fractional Executive Support: We step in as hands-on leadership, providing the strategic and operational expertise startups need to execute with confidence.